Menorrhagia Clinical Trial
Official title:
Treatment and Management of Women With Bleeding Disorders
The purpose of the study is to determine whether oral contraceptives, desmopressin acetate, and/or tranexamic acid are effective in the treatment of women with menorrhagia who are diagnosed with a bleeding disorder.
Status | Completed |
Enrollment | 100 |
Est. completion date | September 2006 |
Est. primary completion date | |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years to 50 Years |
Eligibility |
Inclusion Criteria: - Referred to study by gynecologist or internist/family practitioner with diagnosis of menorrhagia or referred by self through community advertising or networking - Prospective pictorial chart scores of menses >100 - Negative pelvic exam and Pap smear within the past year. *Ultrasound if manual exam indicates abnormal uterine size; *Endometrial biopsy if >35 and non-cyclic bleeding; *Rule out acute pelvic diseases – gonorrhea, chlamydia - Age 18-50 - Willing to go off oral contraceptives and selected drugs (including some nutritional supplements and drugs that affect coagulation such as aspirin and ibuprofen) for initial laboratory testing and throughout the cross-over drug portion of the study - Periods at least every 39 days Exclusion Criteria: - Patient is not proficient in English - Patient is pregnant - Patient on hormone replacement, Depo-Provera, or Norplant in last three months - Patient has intrauterine device (IUD) present - Patient is taking warfarin sodium (Coumadin) or other anti-coagulation therapy - History of documented vascular disease (coronary artery disease, cerebrovascular disease or stroke, transient ischemic attack, peripheral vascular disease) - Uncontrolled hypertension - Insulin dependent diabetes mellitus - Chronic renal or liver disease - History of seizure disorder - History of cancer (other than non-invasive skin cancer) - History of venous or arterial thromboembolism - Patient with a previously diagnosed bleeding disorder has taken or is taking desmopressin acetate or antifibrinolytic drugs for treatment of heavy menstrual bleeding |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Prevention
Country | Name | City | State |
---|---|---|---|
United States | Emory University School of Medicine | Atlanta | Georgia |
United States | Duke University Medical Center | Durham | North Carolina |
United States | Michigan State University | East Lansing | Michigan |
United States | UMDNJ Robert Wood Johnson Medical School | New Brunswick | New Jersey |
United States | Mary M. Gooley Hemophilia Center | Rochester | New York |
United States | The Mayo Clinic | Rochester | Minnesota |
Lead Sponsor | Collaborator |
---|---|
Centers for Disease Control and Prevention |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Reduction of menstrual blood loss as measured by a Pictorial Self-Assessment Chart | |||
Primary | Changes in quality of life |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02824224 -
Tamoxifen to Reduce Unscheduled Bleeding in New Users of the Levonorgestrel-releasing Intrauterine System (LNG-IUS)
|
Phase 4 | |
Withdrawn |
NCT01651468 -
The Effect of the Nutraceutical "Hemofix" on the Coagulation System
|
N/A | |
Recruiting |
NCT02616731 -
Oral Tranexamic Acid Versus Diosmin for Treatment of Menorrhagia in Women Using Copper IUD
|
Phase 1/Phase 2 | |
Terminated |
NCT02087228 -
Evaluation of the Endometrial Cavity After Endometrial Ablation
|
N/A | |
Withdrawn |
NCT00953641 -
Vaginal Misoprostol for Cervical Ripening Prior to Endometrial Biopsy
|
Phase 3 | |
Completed |
NCT01436903 -
Chances for Success of CavatermTM Surgery as a Function of Uterus Probe Length
|
Phase 4 | |
Withdrawn |
NCT00768742 -
Safety and Effectiveness Study of RF Ablation of Uterine Fibroids to Reduce Menstrual Bleeding: the Fibroid Ablation Study
|
N/A | |
Completed |
NCT00156195 -
Study to Evaluate the Safety of Asoprisnil in the Treatment of Uterine Fibroids
|
Phase 3 | |
Completed |
NCT00152256 -
A Study to Evaluate of the Safety and Effectiveness of Asoprisnil in Treating Women With Uterine Fibroids
|
Phase 3 | |
Completed |
NCT00160381 -
A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Uterine Fibroids
|
Phase 3 | |
Completed |
NCT02228174 -
Sonography Guided Transcervical Ablation of Uterine Fibroids
|
N/A | |
Terminated |
NCT01969396 -
Evaluation of the Goldstein SonoBiopsy™ Catheter for Diagnosing Endometrial Pathology
|
N/A | |
Completed |
NCT00393198 -
Bleeding Pattern and User Satisfaction During Second Consecutive MIRENA® in Contraception and Treatment of Menorrhagia
|
Phase 4 | |
Completed |
NCT00386308 -
Efficacy and Safety Study of XP12B in Women With Menorrhagia
|
Phase 3 | |
Completed |
NCT00966264 -
Hysterectomy and Levonorgestrel Releasing Intrauterine System (LNG-IUS) in the Treatment of Menorrhagia
|
Phase 3 | |
Completed |
NCT00904709 -
The Assessment of Tranexamic Acid in Women With Menorrhagia Who Have Bleeding Disorders
|
Phase 4 | |
Recruiting |
NCT03670680 -
Efficiency of Lina LibrataTM System
|
N/A | |
Completed |
NCT02584088 -
Ultrasound Appearance of the Endometrium Post Radio-Frequency Ablation
|
||
Completed |
NCT02835391 -
PerClot Compared to Usual Care in Gynaecology Procedures
|
N/A | |
Completed |
NCT02304510 -
Prevalence of Heavy Menstrual Bleeding in Female Population Living in Beijing
|